Cardiovascular actions of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) a new alpha-adrenergic receptor antagonist.
European journal of pharmacology
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Adrenergic Neurons and Receptors
Oct 17, 2017
Noradrenaline acts on two types of receptors: Adrenergic Receptors
Sep 30, 2017
α-Adrenergic Antagonists for PTSD and Substance Use Disorders
Andrew J. Saxon + 1 • Oct 24, 2017